Swedish Orphan Biovitrum
Nina Brenden, PhD, is a seasoned toxicologist with extensive experience in the biopharmaceutical industry. Currently serving as Senior Toxicologist and Director of Non-Clinical Pharmacology at Sobi since March 2020, Nina Brenden provides expertise in safety, toxicology, and immunotoxicology for drug support, alongside managing in vitro assay development and risk assessments. Prior roles include Senior Toxicologist and Non-Clinical Team Lead at Sobi, Principal Scientist in Immunotoxicology at H. Lundbeck A/S, and Associate Principal Scientist at AstraZeneca R&D, focusing on immunotoxicology mechanisms and drug-induced injuries. Nina Brenden's academic background includes a PhD in Immunology and a BSc in Chemistry & Microbiology from Stockholm University.
This person is not in any teams
This person is not in any offices